Redox Compound

Methylene Blue

Methylthioninium Chloride • Mitochondrial Redox Support

Methylene blue is a synthetic oxidation-reduction compound with a long history in medicine and laboratory science. At low concentrations it can cycle between oxidized and reduced forms, interact with mitochondrial electron transport, and has been studied for effects on cellular energy, memory, and neuroprotection.

Mitochondria Cognition Research Oral Capsule

Protocol Snapshot

Methylene Blue Quick Reference

Verified Vendors

Methylene Blue

Compare Verified Vendors

Current price and availability
Price per mg and vial-size comparison
Testing and fulfillment details

Compare

View Price Index

Common Research Dose

5–20mg

Once daily; available capsule strength is 20mg.

Cycle Length

Short Trial

Reassess tolerability rather than using continuously by default.

Suggested Timing

Morning

Morning or early afternoon to reduce the chance of sleep disruption.

Class

Redox compound

Review the full protocol details below.

Peptide Grade

GradeB

Longstanding medical use and a strong mitochondrial rationale make low-dose research compelling, but dose sensitivity, drug interactions, and product-grade concerns demand caution.

Research Community Safety

Foundation

Research context, mechanisms, and practical use cases

What is Methylene Blue?

Methylene blue, also called methylthioninium chloride, is a synthetic thiazine dye and redox-active drug. It is not a peptide. Its FDA-approved injectable use is for acquired methemoglobinemia, a condition in which hemoglobin cannot carry oxygen normally.

In mitochondrial research, methylene blue can accept and donate electrons. At low concentrations, this redox cycling may support electron transport, reduce electron leakage, and influence cytochrome oxidase activity. It also readily enters the brain and has been investigated for memory, attention, neuroprotection, and mood.

A Real Drug, Not a Harmless Blue Supplement

Methylene blue is a pharmacologically active monoamine oxidase-A inhibitor. Product purity, dose, medications, G6PD status, kidney function, and pregnancy status materially affect safety.

Benefits

Mitochondrial Electron Transport

Low-dose research suggests methylene blue may act as an alternative electron carrier and support mitochondrial respiration under some conditions.

Memory Research

A small randomized human imaging study found increased task-related brain activity and improved memory retrieval after a single low oral dose.

Attention & Processing

Human and preclinical work has explored attention, reaction time, and network-specific cognitive performance, but evidence remains limited.

Neuroprotection Research

Preclinical models suggest antioxidant, anti-inflammatory, and mitochondrial protective effects during cellular stress.

Redox Cycling

Its ability to alternate between oxidized and reduced forms is central to both proposed benefits and dose-dependent risks.

Tau Research

Methylthioninium compounds have been studied for tau aggregation and Alzheimer’s disease, with mixed clinical results.

What to Expect

Same Day — Visible Color Changes

Blue or blue-green urine, stool, saliva, or tongue discoloration can occur and does not by itself indicate toxicity.

Hours — Possible Acute Effects

Some users report alertness or mental clarity, while others experience nausea, headache, dizziness, anxiety, or no noticeable effect.

1–2 Weeks — Evaluate Tolerability

Sleep, mood, blood pressure, GI symptoms, medication interactions, and urinary color changes should be tracked before considering continued use.

Long Term — Evidence Remains Limited

Long-term low-dose use for longevity, cognition, or mitochondrial optimization is not an FDA-approved indication and lacks a validated wellness protocol.

Protocol Planning

Dosing, cycling, and preparation

Methylene Blue Dosing Protocol

There is no FDA-approved oral wellness dose for methylene blue. Published human studies have used widely different formulations and doses, so the ranges below reflect conservative community practice rather than an established treatment protocol.

Conservative Capsule Protocol

Start

5mg once daily

Common Range

5–20mg once daily

Timing

Morning or early afternoon

Route

Oral capsule with water

Duration

Short trial with reassessment; avoid automatic continuous use

Anecdotal Data Points

Community-reported outcomes and recurring patterns

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

Some users report sharper focus, alertness, or improved mental energy at low doses.

Negative Reports

Headache, nausea, dizziness, anxiety, and sleep disruption are commonly discussed, particularly as dose increases.
Blue-green urine and other body-fluid discoloration are expected visible effects.
Liquid products commonly stain the mouth, teeth, clothing, and nearby surfaces.
Lack of noticeable cognitive benefit is common and does not justify rapid dose escalation.

Stacking & Synergy

Potential Methylene Blue pairings and tracking context

Stacking & Synergy

Methylene Blue + Red Light

Both are studied for mitochondrial and photobiomodulation pathways. The combination is popular in longevity communities, but validated human synergy and optimal timing are not established.

Methylene Blue + NAD+

Both affect cellular redox biology, but combining them has not been shown to produce superior clinical outcomes and may complicate interpretation of side effects.

Do Not Stack With Serotonergic Drugs

SSRIs, SNRIs, MAOIs, several opioids, dextromethorphan, buspirone, and other serotonergic agents can create a serious serotonin-syndrome risk.

Methylene Blue + Stimulants

Caffeine and prescription stimulants may compound anxiety, insomnia, heart-rate, or blood-pressure effects in sensitive users.

Free with login

Track in Journal

Track Methylene Blue with the markers that matter most for this compound.

Dose, product concentration, timing, and trial day.
Focus, mental clarity, memory, and task performance.
Energy, sleep, medication context, and any adverse effects.

Start Tracking

Safety Notes

Side effects, contraindications, and precautions

Side Effects

Methylene blue has dose-dependent pharmacology. Safety information from approved intravenous use does not establish the safety of unsupervised oral longevity or nootropic use.

Serotonin syndrome can be life-threatening. Warning signs include agitation, confusion, sweating, fever, rapid heart rate, unstable blood pressure, tremor, rigidity, clonus, diarrhea, or seizures.

Common or Expected

Blue or green urine and stool.
Tongue, saliva, or skin discoloration.
Nausea, abdominal discomfort, or diarrhea.
Headache, dizziness, or dry mouth.

Serious or Important

Serotonin syndrome.
Hemolytic anemia, especially with G6PD deficiency.
Allergic or anaphylactic reactions.
Hypertension, palpitations, confusion, vision changes, or seizures.

Contraindications & Precautions

Do Not Use If You Have

G6PD deficiency, because methylene blue can cause severe hemolysis and anemia.
Known hypersensitivity to methylene blue or other thiazine dyes.
Pregnancy or breastfeeding unless specifically directed for a medically necessary indication.
Current use of serotonergic medications or substances without specialist oversight.

Use Caution With

Kidney or liver impairment, which may increase exposure or delay clearance.
High blood pressure, seizure disorders, bipolar disorder, anxiety, or significant sleep disturbance.
Upcoming surgery, anesthesia, pulse-oximetry monitoring, or urine testing.
Any product that is not verified pharmaceutical or USP grade.

Drug Interactions

Avoid combining methylene blue with SSRIs, SNRIs, MAO inhibitors, bupropion, buspirone, clomipramine, mirtazapine, linezolid, dextromethorphan, serotonergic migraine drugs, and several opioids unless a qualified prescriber has reviewed the combination.

Regulatory Status

FDA-approved methylene blue is an injectable prescription drug for acquired methemoglobinemia. Oral capsule use for cognition, longevity, mood, mitochondrial support, or neuroprotection is off-label and is not an FDA-approved wellness indication.

Methylene blue is not a peptide. It is included here because of its popularity in mitochondrial and longevity protocols.

FINAL VERDICT

Peptide Protocol's Opinionated Opinion

This is not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

We like low-dose Methylene Blue for mitochondrial energy and cognitive sharpness. Some users report noticeable improvements in mental clarity, focus, and endurance when MOTS-c or NAD+ felt too subtle or slow to kick in. It tends to give a faster subjective “lift” than pure mito peptides for brain fog and daily drive, though the mechanism is different.

However, higher doses can cause issues like blue urine or increased anxiety, which is why we stay conservative. Effective in the proper range, but not without caveats. Works well for some people who didn’t get enough from MOTS-c or Humanin, but others find it less smooth than those options. Use responsibly and stay at low doses to avoid the more unpleasant sides. It has its place when other mitochondrial supports fall short, but it’s not our first-line choice for everyone.